Literature DB >> 33237535

Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.

Kirsten Bruderek1, Ronja Schirrmann1, Sven Brandau2.   

Abstract

Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of pathologically expanded myeloid cells with immunosuppressive activity. According to their phenotype, MDSC can be divided into three major subpopulations: early stage MDSC (e-MDSC), lacking myeloid lineage markers, monocytic MDSC (M-MDSC), and granulocytic MDSC (PMN-MDSC). Additionally, PMN-MDSC can be subdivided based on their activation and differentiation status, although it is not clear how this status contributes to immunosuppression and disease pathology. Here, we describe an immunophenotyping and gating strategy for the identification and isolation of MDSC subsets based on fluorescence-activated cell sorting. This method allows direct comparison of MDSC subsets in clinical settings.

Entities:  

Keywords:  Cancer; Circulating MDSC; Flow cytometry; Immunophenotyping; Immunosuppression; Neutrophils

Mesh:

Substances:

Year:  2021        PMID: 33237535     DOI: 10.1007/978-1-0716-1060-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  DAT and TH expression marks human Parkinson's disease in peripheral immune cells.

Authors:  Adithya Gopinath; Phillip Mackie; Basil Hashimi; Anna Marie Buchanan; Aidan R Smith; Rachel Bouchard; Gerry Shaw; Martin Badov; Leila Saadatpour; Aryn Gittis; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Parastoo Hashemi; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2022-06-07

Review 2.  Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad.

Authors:  Yongtong Ge; Dalei Cheng; Qingzhi Jia; Huabao Xiong; Junfeng Zhang
Journal:  Immune Netw       Date:  2021-05-26       Impact factor: 6.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.